866
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies

, , &
Pages 1137-1145 | Accepted 09 Jul 2013, Published online: 02 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Eric L. Johnson, Juan P. Frias & Jennifer M. Trujillo. (2018) Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin. Postgraduate Medicine 130:4, pages 365-374.
Read now
Frank Lavernia, Pamela Kushner, Dace Trence, Donna Rice, George Dailey & Louis Kuritzky. (2015) Recognizing and minimizing hypoglycemia: The need for individualized care. Postgraduate Medicine 127:8, pages 801-807.
Read now

Articles from other publishers (6)

Rebecca S. Holmes, Elizabeth Crabtree & Marian S. McDonagh. (2019) Comparative effectiveness and harms of long‐acting insulins for type 1 and type 2 diabetes: A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism 21:4, pages 984-992.
Crossref
Philip Home, Francoise Calvi-Gries, Lawrence Blonde, Valerie Pilorget, Joseph Berlingieri & Nick Freemantle. (2018) Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study. Diabetes, Obesity and Metabolism 20:4, pages 921-929.
Crossref
Paolo Pozzilli, Paul Norwood, Esteban Jódar, Melanie J. Davies, Tibor Ivanyi, Honghua Jiang, D. Bradley Woodward & Zvonko Milicevic. (2017) Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9). Diabetes, Obesity and Metabolism 19:7, pages 1024-1031.
Crossref
Ildiko LingvayJason ChaoMehul R. DalalLuigi F. Meneghini. (2017) Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures. Diabetes Technology & Therapeutics 19:5, pages 315-322.
Crossref
A.-J. Scheen. (2016) Instauration d’une insulinothérapie chez le patient diabétique de type 2 en médecine générale : Comparaison de l’étude belge InsuStar avec quelques études françaises et internationales. Médecine des Maladies Métaboliques 10:4, pages 334-340.
Crossref
Raymond Miao, Wenhui Wei, Jay Lin, Lin Xie & Onur Baser. (2014) Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes. Journal of Diabetes Science and Technology 8:1, pages 150-158.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.